FDA Inspection 1275086 — Catalent Pharma Solutions, LLC

Catalent Pharma Solutions, LLC — FEI 3007617094

The FDA completed an inspection of Catalent Pharma Solutions, LLC on June 5, 2025 in Philadelphia, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
June 5, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Philadelphia, PA (United States)